Latest news with #AWSCleanRooms
Business Wire
2 days ago
- Business
- Business Wire
Affinity Solutions' Consumer Purchase Insights is Now Accessible via AWS Clean Rooms to Enable Advertisers and Publishers to Securely Drive Outcomes Measurement
NEW YORK--(BUSINESS WIRE)--Affinity Solutions, the leading consumer purchase insights company, today announced it is teaming up with Amazon Web Services (AWS) to provide advertisers and publishers with privacy-enhancing controls to securely access Affinity's Consumer Purchase Insights using AWS Clean Rooms. Advertisers and publishers will have more control over how they activate, measure, and optimize campaigns by securely collaborating with Affinity via AWS Clean Rooms and receiving access to fully permissioned consumer purchase insights from more than 95 million consumers, representing over 86 billion transactions—all without sharing or copying one another's underlying data. Forward-thinking companies seek to generate unique data-driven insights to clearly measure outcomes. To do so, they often need to strategically collaborate with their partners to analyze their collective data sets. However, with increasing privacy regulations and consumer expectations for data protection, companies and their partners need solutions to collaborate safely, without compromising data privacy. AWS Clean Rooms enables a secure and controlled environment that helps Affinity Solutions and its customers to safely integrate Affinity's deterministic transaction data with other data sets, without having to share or reveal raw data. Affinity's Consumer Purchase Insights provides a complete and granular view of spending behaviors across brands and categories, to inform a wide array of growth strategies. With this expanded relationship, advertisers and publishers can now match and measure their first-party data with Consumer Purchase Insights within a trusted environment, providing a more comprehensive view of the customer journey. 'As first-party data remains critical for advertisers to drive business growth, having the right safeguards in place to leverage that data responsibly is essential,' said Ken Barbieri, Senior Vice President, Business Development at Affinity Solutions. 'By expanding our collaboration with AWS, we're empowering advertisers and publishers to measure real-world outcomes with greater speed, precision, and confidence, while providing tools for customers to comply with today's data-privacy standards.' Additionally, advertisers and publishers can measure and model campaign outcomes with greater flexibility, using their own custom ML models and methodologies using AWS Clean Rooms. With AWS Clean Rooms ML, companies can apply privacy-enhancing controls to safeguard their proprietary data and ML models with partners while generating predictive insights—all without sharing or copying one another's raw data or models. Using PySpark in AWS Clean Rooms enables companies and their partners to bring PySpark code and libraries, and run advanced analyses across large datasets without having to share underlying data or proprietary analysis methods. These capabilities help marketers analyze Affinity's Consumer Purchase Insights alongside their own proprietary outcomes data creating opportunities to enhance the measurement of their return on ad spend. Furthermore, the always-on capability enables brands already storing their data on AWS to seamlessly analyze their datasets using AWS Clean Rooms, accelerating the path to potentially actionable campaign insights and measurable ROI. 'Our industry is continuously raising the bar on privacy standards and the technology used to gain insights while providing mechanisms for customers to protect their data. We're pleased Affinity Solutions is leveraging AWS Clean Rooms to offer their customers a secure environment where they can analyze Affinity Solutions' transaction data alongside their own first-party data, driving valuable insights and potentially improving business outcomes,' said Eric Saccullo, Senior Business Development Manager, Applied AI Solutions for Advertising & Marketing at AWS. To learn more about Affinity Solutions, please visit About Affinity Solutions Affinity Solutions is the leading consumer purchase insights company. We provide a complete view of U.S. and U.K. consumer spending, across and between brands, via exclusive access to fully permissioned data from over 150 million debit and credit cards. Our proprietary AI technology, Comet™, transforms these purchase signals into actionable insights for business and marketing leaders to drive optimal outcomes and build lasting customer relationships. Visit us at to discover how we're shaping the future of consumer purchase insights.
Yahoo
2 days ago
- Business
- Yahoo
Affinity Solutions' Consumer Purchase Insights is Now Accessible via AWS Clean Rooms to Enable Advertisers and Publishers to Securely Drive Outcomes Measurement
Expanded relationship equips advertisers and publishers with privacy-enhanced controls to leverage first-party data, creating opportunities to measure and optimize ad campaigns using AWS Clean Rooms NEW YORK, June 12, 2025--(BUSINESS WIRE)--Affinity Solutions, the leading consumer purchase insights company, today announced it is teaming up with Amazon Web Services (AWS) to provide advertisers and publishers with privacy-enhancing controls to securely access Affinity's Consumer Purchase Insights using AWS Clean Rooms. Advertisers and publishers will have more control over how they activate, measure, and optimize campaigns by securely collaborating with Affinity via AWS Clean Rooms and receiving access to fully permissioned consumer purchase insights from more than 95 million consumers, representing over 86 billion transactions—all without sharing or copying one another's underlying data. Forward-thinking companies seek to generate unique data-driven insights to clearly measure outcomes. To do so, they often need to strategically collaborate with their partners to analyze their collective data sets. However, with increasing privacy regulations and consumer expectations for data protection, companies and their partners need solutions to collaborate safely, without compromising data privacy. AWS Clean Rooms enables a secure and controlled environment that helps Affinity Solutions and its customers to safely integrate Affinity's deterministic transaction data with other data sets, without having to share or reveal raw data. Affinity's Consumer Purchase Insights provides a complete and granular view of spending behaviors across brands and categories, to inform a wide array of growth strategies. With this expanded relationship, advertisers and publishers can now match and measure their first-party data with Consumer Purchase Insights within a trusted environment, providing a more comprehensive view of the customer journey. "As first-party data remains critical for advertisers to drive business growth, having the right safeguards in place to leverage that data responsibly is essential," said Ken Barbieri, Senior Vice President, Business Development at Affinity Solutions. "By expanding our collaboration with AWS, we're empowering advertisers and publishers to measure real-world outcomes with greater speed, precision, and confidence, while providing tools for customers to comply with today's data-privacy standards." Additionally, advertisers and publishers can measure and model campaign outcomes with greater flexibility, using their own custom ML models and methodologies using AWS Clean Rooms. With AWS Clean Rooms ML, companies can apply privacy-enhancing controls to safeguard their proprietary data and ML models with partners while generating predictive insights—all without sharing or copying one another's raw data or models. Using PySpark in AWS Clean Rooms enables companies and their partners to bring PySpark code and libraries, and run advanced analyses across large datasets without having to share underlying data or proprietary analysis methods. These capabilities help marketers analyze Affinity's Consumer Purchase Insights alongside their own proprietary outcomes data creating opportunities to enhance the measurement of their return on ad spend. Furthermore, the always-on capability enables brands already storing their data on AWS to seamlessly analyze their datasets using AWS Clean Rooms, accelerating the path to potentially actionable campaign insights and measurable ROI. "Our industry is continuously raising the bar on privacy standards and the technology used to gain insights while providing mechanisms for customers to protect their data. We're pleased Affinity Solutions is leveraging AWS Clean Rooms to offer their customers a secure environment where they can analyze Affinity Solutions' transaction data alongside their own first-party data, driving valuable insights and potentially improving business outcomes," said Eric Saccullo, Senior Business Development Manager, Applied AI Solutions for Advertising & Marketing at AWS. To learn more about Affinity Solutions, please visit About Affinity Solutions Affinity Solutions is the leading consumer purchase insights company. We provide a complete view of U.S. and U.K. consumer spending, across and between brands, via exclusive access to fully permissioned data from over 150 million debit and credit cards. Our proprietary AI technology, Comet™, transforms these purchase signals into actionable insights for business and marketing leaders to drive optimal outcomes and build lasting customer relationships. Visit us at to discover how we're shaping the future of consumer purchase insights. View source version on Contacts Media Contact Sara Serbanoiusserbanoiu@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
15-05-2025
- Business
- Business Wire
Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data
NEW YORK--(BUSINESS WIRE)--Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) platform that powers critical decision-making in healthcare. With this acquisition, Aetion will join Datavant to deliver an end-to-end RWE platform, enabling healthcare and life sciences companies to more efficiently answer research questions about the clinical impact of therapies in development and in market. The companies will focus on leveraging their complementary capabilities to create an end-to-end offering on data discovery, linkage, privacy, curation and advanced analysis to enable their life sciences customers to create analytics-ready insights. Share This complementary combination unites two leaders to make RWE truly actionable, covering the full spectrum of services needed to deliver scientifically validated, transparent and reproducible RWE accepted by global regulators, including the FDA and EMA. Aetion brings industry-leading technology, services and data partners to help life science and medical device customers develop decision-grade evidence plans and analyses. Stakeholders across the healthcare value chain use Datavant's industry-standard platform for secure, compliant health data exchange to fuel connected, comprehensive insights that empower smarter decisions and advance patient outcomes. 'As Datavant has grown and scaled, our life sciences and ecosystem partners have been asking us for a deeper capability set to bring together disparate data sources so they can tap into a more comprehensive and longitudinal view of patient health across the product lifecycle," said Kyle Armbrester, Chief Executive Officer, Datavant. 'The addition of Aetion's team of scientists and technologists further bolsters our complementary capabilities and expertise so we can better leverage data from our ecosystem of partners to support efforts before, during, and after commercialization - generating evidence from trial to treatment and beyond to deliver life-improving therapies.' The companies will focus on leveraging their complementary capabilities to create an end-to-end offering on data discovery, linkage, privacy, curation and advanced analysis to enable their ecosystem and life sciences partners to create analytics-ready insights. This announcement follows the launch of Datavant Connect powered by AWS Clean Rooms, an enhanced capability that facilitates cloud-first data discovery and evaluation to accelerate time to insight. Through Datavant Connect, ecosystem partners' data is more easily and equitably accessible and able to be combined with complementary data sources, thus unlocking additional value to partners and customers alike. Aetion greatly enhances the Datavant Connect platform's data discovery features, and will enhance privacy assessments and give end-customers clean datasets and analytics they can leverage for a range of uses. In addition, the Aetion Evidence Platform is now available in AWS Marketplace. This announcement also coincides with the launch of Aetion® Activate. Activate expands Aetion's software portfolio to better serve biostatisticians and data scientists, creating a collaborative, auditable, and secure platform for both code and no-code users. It also removes the burdens of manual, error-prone data preparation—freeing teams to focus on research and critical analysis. Together with Datavant's connectivity and tokenization capabilities, Aetion now offers a more integrated ecosystem for preparing and analyzing real-world data at scale. 'Our mission at Aetion has always been to power critical decisions in healthcare with data science-driven technology,' said Jeremy Rassen, ScD, CEO of Aetion. 'By joining forces with Datavant, we'll unlock the full potential of real-world evidence to advance confident, data-driven decisions that improve patient care. Today, we are taking a bold step toward realizing our shared vision: a world where health data is seamlessly connected and actionable—so we can answer what treatments work, for whom, and what they should cost.' Upon closing, Datavant and Aetion will have a combined ecosystem of over 300 data partners. Datavant's RWD partners comprise datasets across electronic health records, claims, specialty pharmacy, registries, imaging, lab, social determinants of health, and more. With Aetion, RWD partners across the Datavant ecosystem will gain improved visibility of their data's utility through sharper querying of the datasets, scaling value, demand, and additional use cases across a more expansive base of life sciences companies. About Datavant Datavant is a health data platform company. We make the world's health data secure, accessible, and actionable. Datavant drives data connectivity into action by offering a proprietary platform and network that deliver critical solutions across the healthcare ecosystem. Datavant enables more than 60 million healthcare records to move between thousands of organizations, more than 70,000 hospitals and clinics, 75% of the 100 largest health systems, and an ecosystem of 300+ real-world data partners. To learn more about Datavant, visit and follow us on LinkedIn. About Aetion Aetion® is a global healthcare technology company that delivers real-world evidence (RWE) solutions to biopharmaceutical companies, medical device manufacturers, payers, and regulators. Powered by Aetion Evidence Platform®, Aetion applies advanced causal inference, rigorous epidemiologic methods, and purpose-built AI to transform complex healthcare data into transparent, reliable evidence on the safety, effectiveness, and value of medical treatments. Through this evidence-based approach, Aetion informs healthcare's most critical decisions—what works best, for whom, and when—while enabling scalable solutions for regulatory submissions, market access, and clinical development. Aetion's investors include Flare Capital Partners, NEA, Warburg Pincus, B Capital, and leading life sciences and payer organizations. Learn more at and follow us on LinkedIn.
Yahoo
15-05-2025
- Business
- Yahoo
Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data
Combination will enable faster, more actionable insights across the clinical and commercial lifecycle NEW YORK, May 15, 2025--(BUSINESS WIRE)--Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) platform that powers critical decision-making in healthcare. With this acquisition, Aetion will join Datavant to deliver an end-to-end RWE platform, enabling healthcare and life sciences companies to more efficiently answer research questions about the clinical impact of therapies in development and in market. This complementary combination unites two leaders to make RWE truly actionable, covering the full spectrum of services needed to deliver scientifically validated, transparent and reproducible RWE accepted by global regulators, including the FDA and EMA. Aetion brings industry-leading technology, services and data partners to help life science and medical device customers develop decision-grade evidence plans and analyses. Stakeholders across the healthcare value chain use Datavant's industry-standard platform for secure, compliant health data exchange to fuel connected, comprehensive insights that empower smarter decisions and advance patient outcomes. "As Datavant has grown and scaled, our life sciences and ecosystem partners have been asking us for a deeper capability set to bring together disparate data sources so they can tap into a more comprehensive and longitudinal view of patient health across the product lifecycle," said Kyle Armbrester, Chief Executive Officer, Datavant. "The addition of Aetion's team of scientists and technologists further bolsters our complementary capabilities and expertise so we can better leverage data from our ecosystem of partners to support efforts before, during, and after commercialization - generating evidence from trial to treatment and beyond to deliver life-improving therapies." The companies will focus on leveraging their complementary capabilities to create an end-to-end offering on data discovery, linkage, privacy, curation and advanced analysis to enable their ecosystem and life sciences partners to create analytics-ready insights. This announcement follows the launch of Datavant Connect powered by AWS Clean Rooms, an enhanced capability that facilitates cloud-first data discovery and evaluation to accelerate time to insight. Through Datavant Connect, ecosystem partners' data is more easily and equitably accessible and able to be combined with complementary data sources, thus unlocking additional value to partners and customers alike. Aetion greatly enhances the Datavant Connect platform's data discovery features, and will enhance privacy assessments and give end-customers clean datasets and analytics they can leverage for a range of uses. In addition, the Aetion Evidence Platform is now available in AWS Marketplace. This announcement also coincides with the launch of Aetion® Activate. Activate expands Aetion's software portfolio to better serve biostatisticians and data scientists, creating a collaborative, auditable, and secure platform for both code and no-code users. It also removes the burdens of manual, error-prone data preparation—freeing teams to focus on research and critical analysis. Together with Datavant's connectivity and tokenization capabilities, Aetion now offers a more integrated ecosystem for preparing and analyzing real-world data at scale. "Our mission at Aetion has always been to power critical decisions in healthcare with data science-driven technology," said Jeremy Rassen, ScD, CEO of Aetion. "By joining forces with Datavant, we'll unlock the full potential of real-world evidence to advance confident, data-driven decisions that improve patient care. Today, we are taking a bold step toward realizing our shared vision: a world where health data is seamlessly connected and actionable—so we can answer what treatments work, for whom, and what they should cost." Upon closing, Datavant and Aetion will have a combined ecosystem of over 300 data partners. Datavant's RWD partners comprise datasets across electronic health records, claims, specialty pharmacy, registries, imaging, lab, social determinants of health, and more. With Aetion, RWD partners across the Datavant ecosystem will gain improved visibility of their data's utility through sharper querying of the datasets, scaling value, demand, and additional use cases across a more expansive base of life sciences companies. About Datavant Datavant is a health data platform company. We make the world's health data secure, accessible, and actionable. Datavant drives data connectivity into action by offering a proprietary platform and network that deliver critical solutions across the healthcare ecosystem. Datavant enables more than 60 million healthcare records to move between thousands of organizations, more than 70,000 hospitals and clinics, 75% of the 100 largest health systems, and an ecosystem of 300+ real-world data partners. To learn more about Datavant, visit and follow us on LinkedIn. About Aetion Aetion® is a global healthcare technology company that delivers real-world evidence (RWE) solutions to biopharmaceutical companies, medical device manufacturers, payers, and regulators. Powered by Aetion Evidence Platform®, Aetion applies advanced causal inference, rigorous epidemiologic methods, and purpose-built AI to transform complex healthcare data into transparent, reliable evidence on the safety, effectiveness, and value of medical treatments. Through this evidence-based approach, Aetion informs healthcare's most critical decisions—what works best, for whom, and when—while enabling scalable solutions for regulatory submissions, market access, and clinical development. Aetion's investors include Flare Capital Partners, NEA, Warburg Pincus, B Capital, and leading life sciences and payer organizations. Learn more at and follow us on LinkedIn. View source version on Contacts Media Contact Lynn ShepherdHead of Corporate Communications, Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
13-05-2025
- Business
- Associated Press
OneMedNet Enhances Data Discovery and Analytics with the Datavant Connect platform and Amazon Web Service (AWS) Clean Rooms
MINNEAPOLIS, May 13, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ('OneMedNet' or the 'Company'), the leading provider of regulatory-grade imaging Real-World Data (iRWD) today has announced its adoption of expanded capabilities within the Datavant Connect platform to accelerate healthcare data discovery, analytics, and partner assessment processes. These new advancements will be presented by Datavant this week at ISPOR 2025, highlighting the importance of secure, scalable, and fit-for-purpose data solutions in driving innovation across healthcare and life sciences. The healthcare industry has experienced a tremendous volume of health-related data generation—extending beyond patient interactions to include genomic sequencing, biomarker data, and more. In many ways, data has become the new oil, holding immense value for clinical and scientific advancement. However, like crude oil, this raw data must be refined—its fragmented and siloed nature continues to hinder accessibility and usability. As healthcare and life sciences organizations increasingly seek targeted, fit-for-purpose datasets, scalable and secure technological solutions have become essential to unlocking its full potential. Leveraging AWS Clean Rooms, OneMedNet will offer sophisticated data partner assessment and discovery tools through the Datavant Connect platform, enabling secure collaboration environments without direct data movement or sharing of raw data. This 'no underlying data movement' approach significantly enhances data security and privacy, allowing for effective feasibility analyses between data sources and buyers. These advancements facilitate faster identification and evaluation of relevant healthcare datasets, directly addressing the industry's strategic, privacy, and data handling challenges. By empowering healthcare organizations with precise, secure, and efficient data access, OneMedNet accelerates the generation of valuable insights and transformative outcomes. 'Much of today's healthcare data remains untapped due to complexity and interoperability issues,' continued Aaron Green. 'Datavant Connect powered by AWS Clean Rooms effectively removes these barriers, positioning OneMedNet as an indispensable partner for organizations aiming to fully harness the potential of healthcare data.' About OneMedNet Corporation OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,400 healthcare sites through its iRWD™ platform. This isn't just data—it's the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption. Beyond healthcare OneMedNet's proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' or 'hopes' or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin's volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. OneMedNet Contacts: Michael Wong, VP Marketing Email: [email protected] SOURCE: ONEMEDNET CORPORATION
